Globus Medical Inc - Ordinary Shares - Class A
GMED
Market Cap$5.69B
Close$
$79.18
23% upside
Current Fair Value
23% upsideUndervalued by 23% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.69 Billion |
|---|---|
| Enterprise Value | $5.67 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $1.07 |
| Beta | 1.05 |
| Outstanding Shares | 112,624,816 |
| Avg 30 Day Volume | 844,347 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 46.27 |
|---|---|
| PEG | -40.42 |
| Price to Sales | 4.02 |
| Price to Book Ratio | 1.89 |
| Enterprise Value to Revenue | 2.99 |
| Enterprise Value to EBIT | 32.69 |
| Enterprise Value to Net Income | 85 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
ESG Score
No data
About Globus Medical Inc
CEO: David Demski